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Edited by Francesc PosasAbstract The eﬀect of tyrosine nitration on mammalian GS
activity and stability was studied in vitro. Peroxynitrite at a con-
centration of 5 lmol/l produced tyrosine nitration and inactiva-
tion of GS, whereas 50 lmol/l peroxynitrite additionally
increased S-nitrosylation and carbonylation and degradation of
GS by the 20S proteasome. ()Epicatechin completely prevented
both, tyrosine nitration and inactivation of GS by peroxynitrite
(5 lmol/l). Further, a putative ‘‘denitrase’’ activity restored the
activity of peroxynitrite (5 lmol/l)-treated GS. The data point
to a potential regulation of GS activity by a reversible tyrosine
nitration. High levels of oxidative stress may irreversibly damage
and predispose the enzyme to proteasomal degradation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glutamine synthetase (GS; glutamate ammonia ligase, EC
6.3.1.2) catalyzes the conversion of glutamate and ammonia
to glutamine and plays a major role in ammonia detoxiﬁca-
tion, interorgan nitrogen ﬂux, acid–base regulation, cell prolif-
eration and protection from apoptotic stimuli [1].
GS activity is highly susceptible to reactive nitrogen and
oxygen species. For instance, inhibition of nitric oxide (NO)
synthase (NOS) increased GS activity in rat brain and cultured
rat astrocytes [2–4], suggesting that a NOS-dependent genera-
tion of reactive nitrogen species accounts for tonic GS inhibi-
tion in the brain. Further, NOS inhibition protected GS from
N-methyl-D-aspartate (NMDA)-induced inactivation in vital
brain slices [5]. NO may recombine with the superoxide anion
to generate peroxynitrite, which potently nitrates protein tyro-
sine residues [6]. Indeed, GS tyrosine nitration and inactivation
was found in brains of diﬀerent rat models related to hyperam-
monemia and hepatic encephalopathy, in cultured astrocytes
exposed to ammonia, and in livers of septic rats [7–10]. Re-
cently mass spectrometric analysis of peptides derived fromAbbreviation: GS, glutamine synthetase
*Corresponding author. Fax: +49 211 811 17517.
E-mail address: schliess@med.uni-duesseldorf.de (F. Schliess).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.11.081sheep GS inactivated by peroxynitrite in vitro identiﬁed a ni-
trated tyrosine residue corresponding to Tyr335 of rat GS,
which is highly conserved among eukaryotic GS [9,11]. This
tyrosine residue may directly stack with the purine system of
GS-bound ADP/ATP, and in addition might contribute to
the interface with the neighbouring subunit. Hence it seems
plausible that GS activity is sensitive to tyrosine nitration.
However, a potential contribution of oxidative modiﬁcations
diﬀerent from tyrosine nitration to GS inactivation has not
yet been excluded. Further, the impact of tyrosine nitration
and oxidation on the stability of mammalian GS is unknown.
The present study by an in vitro approach examined the con-
tribution of tyrosine nitration and other oxidativemodiﬁcations
to GS inactivation and degradation by the 20S proteasome.2. Materials and methods
2.1. Materials and reagents
A commercial sheep brain GS preparation (G-6632, Sigma, Taufkir-
chen, Germany) was used in this study. Following SDS gel electropho-
resis and Coomassie brilliant blue staining the GS presents as a double
band at about 45 kDa (Fig. 1A). Mass spectrometric analysis con-
ﬁrmed that both bands relate to GS (Dr. Sabine Metzger, Biological
Medical Research Center, Heinrich-Heine-University, Du¨sseldorf,
Germany).
L-Glutamine, hydroxylamine-HCl, adenosine diphosphate, MnCl2,
imidazol-HCl, ()epicatechin and the polyclonal antibodies against
GS and S-nitrosocystein were from Sigma (Taufkirchen, Germany).
The monoclonal anti-GS antibodies were from Transduction-Labora-
tories (San Diego, CA). The monoclonal and polyclonal antibodies
against 3 0-nitrotyrosine were purchased by Upstate Biotechnology
(Lake Placid, NY). The horseradish peroxidase (HRPOD)-coupled
anti-mouse-IgG antibody was from BioRad (Hercules, USA) and the
HRPOD-coupled antibody recognizing rabbit IgG was from DAKO
(CA, USA). The protein A/G agarose was from Santa Cruz Biotech-
nology (Santa Cruz, CA). Peroxynitrite and the puriﬁed 20S protea-
some were from Calbiochem-Novabiochem (Schwalbach, Germany).
Succinyl-leucine-leucine-valine-tyrosine-4-methylcoumarin-7-amide
(Suc-LLVY-MCA) was from Bachem (Weil am Rhein, Germany).
2.2. Peroxynitrite treatment of GS
Sheep GS (500 ng) was treated with peroxynitrite at concentrations
of 0–50 lmol/l in KH2PO4 buﬀer (pH 7.0) under continuous vortexing
in the presence or absence of 30 lmol/l ()epicatechin in a total volume
of 100 ll. The addition of peroxynitrite to the buﬀer system did not lead
to a pH change of the sample. Aliquots were taken for dot blot analysis
of covalent modiﬁcations and determination of enzyme activity.
2.3. Preparation of spleen proteins from lipopolysaccharide-treated rats
The experiments were approved by the responsible local authorities.
Lipopolysaccharide (LPS, dissolved in 0.9% saline) was injected to ratsblished by Elsevier B.V. All rights reserved.
Fig. 1. Peroxynitrite-induced covalent modiﬁcations and inactivation of GS. (A) Representative Coomassie brilliant blue staining of the used
commercial sheep brain GS preparation. (B,C) GS reacted with 0–50 lmol/l peroxynitrite. Samples were analyzed for the indicated modiﬁcation or
GS activity, respectively. (B) Peroxynitrite-induced tyrosine nitration, S-nitrosylation and carbonylation of GS. Representative dot blots of 3–4
independent experiments are shown. Changes in tyrosine nitration, S-nitrosylation and carbonylation were quantiﬁed by densitometry and were
normalized to overall GS immunoreactivity. The level of modiﬁed GS at the zero time point was set to one. (C) Peroxynitrite-induced inactivation of
GS. GS activity was normalized to that found in absence of peroxynitrite. (D) Regression analysis of a linear relationship between GS tyrosine
nitration and relative GS activity.
B. Go¨rg et al. / FEBS Letters 581 (2007) 84–90 85intraperitoneally at a dose of 4 mg/kg body wt and animals were
housed individually. Spleen samples were homogenized with an ultra-
turrax using 10 mmol/l Tris–HCl buﬀer (pH 7.4) containing 1% Triton
X-100, 150 mmol/l NaCl, 10 mmol/l Na4P2O2, 1 mmol/l EDTA,
1 mmol/l EGTA, 20 mmol/l NaF, 1 mmol/l sodium vanadate,
20 mmol/l b-glycerophosphate, and protease inhibitor cocktail (Boeh-
ringer Mannheim, Germany). Lysates were centrifuged at 20000 · g at
4 C and protein concentration of the supernatant was estimated by
the Bradford assay (BioRad, Munic, Germany). Likewise, protein ex-
tracts from liver and cerebral cortices of non LPS-treated rats were
prepared.
2.4. Incubation of peroxynitrite-treated GS with spleen protein from
LPS-treated rats
Peroxynitrite-treated GS (50 ng) was incubated with 40 lg of spleen
protein from LPS-treated rats supplemented with 2 mmol/l MgCl2 and
2 mmol/l CaCl2 in a total volume of 40 ll. For control the putative
‘‘denitrase’’ activity of the spleen extract was inhibited by heating to
95 C for 2 min [12] before incubation with the peroxynitrite-treated
GS. Similar incubations were performed with protein preparations
from rat liver and cerebral cortex. Removal of 3 0-nitrotyrosine immu-
noreactivity was followed by Western- and dot blot analysis.2.5. GS activity assay
The glutamine synthase-catalyzed formation of c-glutamylhydrox-
amate from glutamine and hydroxylamine was measured as described
[9].2.6. Detection of GS carbonylation
To monitor protein carbonylation the OxyBlot-protein oxidation
detection kit (Chemicon) was used. 25 ng GS was denaturated by addi-
tion of SDS (ﬁnal concentration: 6%), followed by derivatization of
carbonyl groups with dinitrophenylhydrazine according to the manu-
facturers protocol. Aliquots were dotted to nitrocellulose and the
2,4-dinitrophenyl (DNP) moiety was detected by using a 1:5000 dilu-
tion of a polyclonal antibody speciﬁcally recognizing DNP. No unspe-
ciﬁc binding of the anti-DNP antibody to the negative control samples
(absence of 2,4-dinitrophenylhydrazine) was observed.2.7. Immunoblotting
GS was analyzed by Western Blotting using 10% SDS–polyacryl-
amide gels and a semi-dry transfer apparatus (Biometra, Fastblot
B33, Go¨ttingen, Germany). For dot blot analysis equal amounts
of GS (10 ng) in a volume of 2 ll were applied to a nitrocellulose
86 B. Go¨rg et al. / FEBS Letters 581 (2007) 84–90membrane. Blots were probed with antisera against GS or 3 0-nitrotyro-
sine (1:5000 in 5% BSA or 1% FCS, respectively) for 1 h at room tem-
perature. Following washing and incubation with horseradish
peroxidase-coupled anti-mouse-IgG or anti-rabbit-IgG antibody
diluted 1:10000 at room temperature for 1 h blots were washed again
and then developed by using the Western-Lightning chemilumines-
cence reagent plus (Perkin-Elmer, Rodgau-Ju¨gesheim, Germany).Fig. 2. Eﬀect of depletion of tyrosine-nitrated GS on GS levels and activity. S
nitrated GS was depleted by an anti 3 0-nitrotyrosine antibody coupled to
tyrosine-nitrated and overall GS and GS activity, respectively. (A) 3 0-Nitr
content of tyrosine-nitrated and overall GS. Samples were treated with prot
coupled to protein A/G agarose (lines 5 and 6). A Western blot representing t
nitrated and overall GS were quantiﬁed by densitometry. The content of t
samples incubated with protein A/G agarose not coupled to the antibody w
peroxynitrite-treated GS on GS activity (n = 8). Samples were treated with
antibody coupled to protein A/G agarose (‘‘PN, NO2Tyr-depleted’’). GS actFor determination of protein S-nitrosylation GS (10 ng) was dotted
immediately after the experimental treatment on nitrocellulose mem-
brane followed by probing with an antibody against S-nitrosocysteine.
In this case probing of the membrane with the antibodies was carried
out in darkness at 4 C for 2 h each. Densitometric analysis was
performed using the Image J software (Wayne Rasband, NIH) or
the Scion Image software (Scion Corporation, Federick, MD).heep GS was treated with 5 lmol/l peroxynitrite (PN). Then, tryosine-
protein A/G agarose. Supernatants were analyzed for the content of
otyrosine immunodepletion of peroxynitrite-treated GS decreases the
ein A/G agarose alone (lines 1–4) or the anti 3 0-nitrotyrosine antibody
hree independent experiments is shown. Changes in content of tyrosine-
yrosine-nitrated and overall GS, respectively, in peroxynitrite-treated
as set to 100%. (B) Eﬀect of anti 3 0-nitrotyrosine immunodepletion of
protein A/G agarose (‘‘Control’’, ‘‘PN’’) or the anti 3 0-nitrotyrosine
ivity in the control sample was set to 100%.
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GS (50 ng) was added to puriﬁed 20S proteasome (1 lg) and incu-
bated in 50 mmol/l HEPES (pH 7.8) containing 20 mmol/l KCl,
5 mmol/l Mg(Ac)2 and 0.03% SDS. The reaction mixture was incu-
bated at 37 C for 6 h. Functionality of the 20S proteasome was veri-
ﬁed by using the ﬂuorogenic peptide Suc-LLVY-MCA. Cleavage of the
peptide was followed ﬂuorimetrically (Ascent-FL, Thermo Electron)
by using an excitation wavelength of 380 nm and collecting the emis-
sion at 460 nm (data not shown).2.9. Statistical analysis
Results are expressed as means ± S.E.M. Results were compared
using the Student’s two-tailed t-test: P < 0.05 was considered statisti-
cally signiﬁcant.Fig. 3. Eﬀect of ()epicatechin on peroxynitrite-induced tyrosine
nitration and inactivation of GS. Sheep GS was treated with 5 lmol/l
peroxynitrite (PN) in presence or absence of ()epicatechin (EC).
Thereafter samples were analyzed for tyrosine-nitrated and overall GS
(A) and GS activity (B) (n = 3).3. Results
3.1. Dose-dependent eﬀects of peroxynitrite on GS covalent
modiﬁcation and activity
As shown in Fig. 1B, peroxynitrite at a concentration of
5 lmol/l increased tyrosine nitration of GS about 4-fold but
was essentially without eﬀect on S-nitrosylation and carbonyl-
ation of the enzyme. At higher peroxynitrite concentrations a
signiﬁcant increase of S-nitrosylation and carbonylation of
the GS was observed. Peroxynitrite dose-dependently de-
creased GS activity (Fig. 1C). At a peroxynitrite concentration
of 5 lmol/l GS activity was decreased by about 25%. Statistical
regression analysis revealed a close linear relationship between
GS tyrosine nitration and relative GS activity (Fig. 1D,
r = 0.97).
To estimate the portion of GS tyrosine-nitrated by 5 lmol/l
peroxynitrite, an agarose-coupled anti 3 0-nitrotyrosine anti-
body was used to deplete tyrosine-nitrated GS. As shown in
Fig. 2A the antibody ﬁshed about 65% of the tyrosine-nitrated
GS, which corresponded to an about 20% loss of overall GS
protein. This extrapolates to a fraction of 30% tyrosine-ni-
trated GS, which is well within the order of GS inactivation
caused by 5 lmol/l peroxynitrite (Fig. 1B). Depletion of tyro-
sine-nitrated GS from peroxynitrite-treated GS only margin-
ally further decreased GS activity (Fig. 2B), suggesting that
tyrosine-nitrated GS does essentially not contribute to GS
activity. It is concluded that tyrosine nitration inactivates
GS.3.2. Epicatechin prevents GS tyrosine nitration and inhibition by
peroxynitrite
The ﬂavonoid epicatechin was shown to interfer with protein
tyrosine nitration by intercepting the tyrosyl radical [13]. Epi-
catechin (30 lmol/l) completely abolished tyrosine nitration of
GS by 5 lmol/l peroxynitrite (Fig. 3). Further, epicatechin
completely prevented GS inactivation by peroxynitrite
(Fig. 3). The data further corroborate that tyrosine nitration
eﬀectively inactivates GS.3.3. A putative ‘‘denitrase’’ activity restores activity of
peroxynitrite-treated GS
A putative nitrotyrosine ‘‘denitrase’’ activity is induced in
spleen after treatment of rats with lipopolysaccharide (LPS)
[12]. In order to examine whether ‘‘denitrase’’ restores GS
activity following tyrosine nitration, peroxynitrite (5 lmol/l)-
treated GS was incubated with spleen protein prepared from
LPS-treated rats. As shown in Fig. 4A the spleen protein didnot add to overall GS (lines 3 and 9) but potently decreased
the 3 0-nitrotyrosine immunoreactivity of the peroxynitrite-
treated GS (lines 2 and 4–7). In line with the reported heat sen-
sitivity of the ‘‘denitrase’’ [12] heated spleen protein was largely
ineﬀective to decrease the levels of tyrosine-nitrated GS (lines
10 and 11).
As shown in Fig. 4B the addition of spleen proteins to GS
untreated with peroxynitrite did not add to GS activity. How-
ever, the addition of spleen proteins following GS inactivation
by peroxynitrite (5 lmol/l) eﬀectively restored the GS activity
essentially to the levels found under the control condition.
The data suggest that denitration of tyrosine-nitrated GS
restores GS activity and imply that GS inactivation due to
tyrosine nitration is reversible.
Fig. 5 shows that incubation of peroxynitrite-treated GS
with protein prepared from cerebral cortex of non LPS-treated
rats also potently decreased the 3 0-nitrotyrosine immunoreac-
tivity of the GS (line 4), whereas the heated protein prepara-
tion and liver proteins were largely ineﬀective (Fig. 5, lines 3
and 5), consistent with the previous report [12]. It is also shown
that the rat protein preparations by themselves only margin-
ally contribute to 3 0-nitrotyrosine immunoreactivity (Fig. 5,
lines 6–9).
3.4. Degradation of peroxynitrite-treated GS by the 20S
proteasome
The reaction of diﬀerent proteins with peroxynitrite in vitro
increased their degradation by the 20S proteasome [14]. In or-
der to examine the impact of tyrosine nitration and oxidative
modiﬁcations on GS degradation by the 20S proteasome, GS
treated with peroxynitrite (5 and 50 lmol/l, respectively) was
incubated with a 20S proteasome preparation. The 20S protea-
some was without eﬀect on the levels of GS that was not
exposed to peroxynitrite (not shown). Likewise, the 20S pro-
teasome was ineﬀective to degrade GS exposed to only
5 lmol/l peroxynitrite as revealed at the levels of tyrosine-
nitrated and overall GS (Fig. 6). However, following treatment
with 50 lmol/l peroxynitrite the GS was susceptible to degra-
dation by the 20S proteasome (Fig. 6). It is suggested that tyro-
sine nitration alone is not suﬃcient to label GS for 20S
proteasomal degradation.
Fig. 4. Spleen homogenates from LPS-treated rats decrease 3 0-nitrotyrosine immunoreactivity and increase activity of peroxynitrite-treated GS. (A)
Peroxynitrite (PN, 5 lmol/l)-treated GS was incubated with aliquots of a spleen protein preparation from LPS-treated rats. Samples were analyzed
for tyrosine-nitrated and overall GS by probing Western- and dot blots with antibodies speciﬁcally recognizing 3 0-nitrotyrosine and GS, respectively.
Peroxynitrite-treated GS was incubated with native (lines 4–7 and 11) or heat-inactivated (lines 8 and 9) spleen extracts for the indicated time periods
(lanes 4–7) or for 30 min (dots 8–11). No tyrosine-nitrated GS was detectable in absence of peroxynitrite treatment (lines 1, 2 and dots 8, 10). Further,
spleen proteins at the used amounts did neither signiﬁcantly add to tyrosine-nitrated, nor overall GS (lines 3 and 9). The bar diagram bases on
densitometric analysis of dot blots (n = 5). (B) Samples were analyzed for GS activity, which was normalized to that found in absence of peroxynitrite
and spleen protein (n = 3).
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Recent evidence suggests that protein tyrosine nitration is a
selective and reversible process and may play a role in the reg-
ulation of signal transduction and metabolism [15]. On the
other hand, tyrosine nitration and/or oxidation may irrevers-
ibly aﬀect the functional structure and increase the susceptibil-
ity of proteins to degradation by the 20S proteasome [14].
As shown in the present study peroxynitrite in vitro already
at a concentration of 5 lmol/l tyrosine nitrated and inactivatedmammalian GS, whereas higher peroxynitrite concentrations
additionally increased S-nitrosylation and carbonylation and
predispose the GS to degradation by the 20S proteasome. In
the case of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) peroxynitrite only at a concentration of 100–
200 lmol/l increased tyrosine nitration to detectable levels
under comparable experimental conditions [16]. Moreover,
oxidation, inactivation and proteasomal degradation of the
GAPDH were produced already at lower peroxynitrite concen-
trations that were ineﬀective to produce tyrosine nitration of
Fig. 5. Homogenates from rat cerebral cortex but not liver decrease
3 0-nitrotyrosine immunoreactivity of peroxynitrite-treated GS. Perox-
ynitrite (PN)-treated GS was incubated with aliquots of protein
homogenates prepared from spleen of LPS-treated rats (control, line 2)
or liver (line 3) and cerebral cortex (native or heated, lines 4 and 5).
Samples were analyzed for protein tyrosine nitration and overall GS by
Western blot. The rat protein preparations by themselves only
marginally contribute to 3 0-nitrotyrosine immunoreactivity (lines 6–9).
Fig. 6. Degradation of tyrosine-nitrated GS by the 20S proteasome. GS trea
the 20S proteasome. Thereafter, samples were analyzed by Western blot for th
tyrosine-nitrated and overall GS were estimated by densitometry. The re
proteasome were set to 100% (n = 3).
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tionally high susceptibility of mammalian GS to tyrosine nitra-
tion by peroxynitrite. Oxidative modiﬁcations diﬀerent from
tyrosine nitration trigger 20S proteasomal degradation of
both, GS and GAPDH.
The presence of epicatechin completely abolished both, tyro-
sine nitration and inactivation of GS by peroxynitrite (5 lmol/
l, this study). Likewise, epicatechin completely abolished tyro-
sine nitration of GS produced by 20 lmol/l peroxynitrite but
only partly prevented GS inactivation under this condition
[9], suggesting that in addition to tyrosine nitration oxidative
GS modiﬁcations could contribute to GS inactivation at higher
peroxynitrite concentrations. On the other hand, the extent of
GS tyrosine nitration correlated signiﬁcantly with inactivation
of the enzyme and denitration of mammalian GS after perox-
ynitrite (5 lmol/l) treatment completely restored GS activity
(this paper), further supporting the conclusion that tyrosine
nitration alone is suﬃcient to inactivate the enzyme, and indi-
cating that GS inactivation by tyrosine nitration is potentially
reversible.
The ﬁndings point to the possibility that cellular GS activity
underlies regulation by tyrosine nitration under (patho)physi-
ological conditions, which would be consistent with some ear-
lier observations. For example, in ammonia-treated cultured
astrocytes tyrosine nitration of GS was associated with its
inactivation [7]. Further, in portocaval anastomized rats,
which represent a hepatic encephalopathy (HE)-related animal
model of chronic liver failure [18], GS in cerebral cortex was
tyrosine-nitrated and inactivated without an accompanying
decrease of GS expression levels [7,19]. On the other hand,
denitration of GS was discussed to account for the release of
cerebral GS activity by inhibition of NOS and NMDA recep-
tors from tonic inhibition [3,4]. A temporary decrease of GS
activity may protect the brain from excessive astrocyte swelling
due to glutamine accumulation in hyperammonemic states.
Further studies are required to clarify cell type speciﬁcity
and regulation of ‘‘denitrase’’ in the brain.
High levels of oxidative stress may irreversibly impair
the functional GS structure and predispose the enzyme forted with peroxynitrite (5 or 50 lmol/l as indicated) was incubated with
e presence of tyrosine-nitrated and overall GS. The relative amounts of
spective levels of tyrosine-nitrated or overall GS in absence of the
90 B. Go¨rg et al. / FEBS Letters 581 (2007) 84–90degradation by the 20S proteasome (this paper). Such a degra-
dation of oxidized GS was supposed to account for the loss of
cerebral GS activity in ischemia/reperfusion injury, Alzheimers
disease, and human aging [20,21].
In summary the in vitro study presented here supports the
scenario that tyrosine nitration can inactivate mammalian
GS in a reversible manner. Higher levels of oxidative stress
may add oxidative modiﬁcations which irreversibly inactivate
GS and promote GS degradation by the 20S proteasome.
Ongoing studies will investigate the role of reversible GS tyro-
sine nitration in the regulation of GS activity in cell culture
models and in vivo.
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